APRIL 30, 2005
VOLUME 2 NO. 8
 

Can hospital data help catch lousy docs?
BIRMINGHAM, UK — The use of hospital data to evaluate doctor performance has a largely bad reputation — and deservedly so. These benchmarks are often inherently skewed to make docs who treat the sickest patients look bad. Bearing this firmly in mind, researchers at the University of Birmingham used hospital data collected over a five-year period to compare disgraced gynecologist Dr Rodney Ledward to 142 of his peers. They found that the reckless Dr Ledward — self-proclaimed "fastest gynecologist in the south-east" — stuck out like a statistical sore thumb in three of those five years. While the study authors urge caution in using such data to condemn docs, they conclude that further evaluation of their method is warranted. The study was posted on April 14th on BMJ Online First.

Tx to make patients laugh, or cry, less
BURLINGTON, VT — Until now, antidepressants were the only treatment for pseudobulbar affect (PBA), a condition in which people are unable to control their emotions, often laughing or crying inappropriately. Another solution was presented at the American Academy of Neurology 57th Annual Meeting in Miami Beach this month. A clinical trial randomized 150 people with multiple sclerosis and PBA to receive either the drug AVP-293 or a placebo for 12 weeks. Those taking AVP-293, a combination of dextromethorphan and quinidine, had 46% fewer emotional episodes than controls and reported an improved quality of life.

Don't go into the light
BODO, NORWAY — After the long, dark days of winter most people look forward to a sunny summer. Some migraine sufferers, however, may be dreading the warm season. Research presented at the same meeting in Miami revealed that nearly half of migraine sufferers with aura had more headaches in the summer than the winter. The study, which interviewed 98 Norwegian women with migraine aura and 71 with migraine and no aura, concluded that the occipital lobe neurons of migraine sufferers were hyperexcitable during exposure to the intense light of summer in the Arctic.

A death unfit for dogs
MIAMI — A study appearing in the April 16 Lancet castigates the US practice of capital punishment by lethal injection. The researchers, led by Dr Leonidas G Koniaris, looked at inmates killed in Texas and Virginia, where 45% of American executions take place. They found a system in utter shambles where executioners often had no training in anesthesia. There's typically scant — or no — medical data collection and no peer review of the executions themselves. What's more, the authors found lethal injection often wouldn't even clear low veterinary standards for putting animals down. An accompanying editorial adds "repeated studies have shown a pattern of racial discrimination in the administration of the death penalty."

Ghostwriters lurking in the journals
WASHINGTON — Dr Adriane Fugh-Berman of Georgetown University delivered a bombshell commentary in the April 14 online edition of the Journal of General Internal Medicine. Entitled "The Corporate Coauthor," her commentary details how she was handed an article, written and paid for by industry interests, and asked to put her name to it as the 'author.' She said the study was on herb warfarin interactions and that the sponsor of the article was developing an alternative to warfarin — a flagrant conflict of interest. Fearing this is not an isolated incident, Dr Fugh-Berman is critical of the current voluntary conflict of interest declarations. She proposes more stringent standards coupled with a searchable public database.

Putting cancer behind
MINNEAPOLIS — Prostate cancer may not just be a pain in the behind as its treatment may also increase the risk of cancer there. A retrospective study of over 85,000 men in the Surveillance, Epidemiology and End Results (SEER) Registry found that those who received radiation therapy for prostate cancer were 70% more likely to later develop rectal cancer. However the report, in the April issue of Gastroenterology, found that the risks of other types of colon cancer weren't affected by the therapy.

It's a boy! And a girl, and another boy...
SAN DIEGO — In humans, multiple births, like the Dionne quints, usually make headlines. For the lowly mouse, on the other hand, they're the norm. A report in the April 4 edition of PNAS explores the genetic factors that make murine multiple births possible — and offers an explanation for this rare phenomenon in humans. Apparently a protein called BMP-15 controls the number of follicles that can ovulate. In humans, it's produced normally, resulting in mainly singleton births. In mice, however, BMP-15 is destroyed before it has a chance to mature. Researchers hope this finding will impact infertility and birth control treatments in humans.

Pin the tail on the bully
SEATTLE — Researchers may be able to pick out future schoolyard bullies as early as age four. A study of 1,266 children in the April issue of the Archives of Pediatric and Adolescent Medicine found that 13% of the four-year olds surveyed were considered bullies by their mothers. These kids were more likely to have watched plenty of TV at age four, and less likely to have received an abundance of emotional support and cognitive stimulation from their parents. Bullying by these kids was later reported at ages six through 11.

Smokeless smokes trump addiction
BIRMINGHAM, AL — We all know that cold turkey is far more appealing between two slices of bread than as a smoking cessation method. That's why the authors of a Journal of Psychoactive Drugs paper came up with the strategy to replace quitters' cigarettes with a smokeless form of tobacco. In the January/February issue, they report that the 75% of subjects who were smoke-free after one year are still smoke-free seven years later. The smokeless tobacco carries a 98% lower risk of dying than the real McCoy.

Tumour-free chinwag
COPENHAGEN — The urban legend that cellphone use can cause brain tumours has at last been debunked. A study in the April 12 issue of Neurology interviewed 427 people with brain tumours and 822 people without these growths about their cell phone use. Phone company records indicated that there was little recall bias, so the finding that there's no relationship whatsoever between brain tumour development and frequent cellphone use is a solid one.

 

 
1
2

 

 

back to top of page

 

 

 

 

 

 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
Site created by Spin Design T.